000 | 01961 a2200517 4500 | ||
---|---|---|---|
005 | 20250516033329.0 | ||
264 | 0 | _c20130124 | |
008 | 201301s 0 0 eng d | ||
022 | _a1099-1263 | ||
024 | 7 |
_a10.1002/jat.1685 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVan Dorst, Bieke | |
245 | 0 | 0 |
_aSelection of scFv phages specific for chloramphenicol acetyl transferase (CAT), as alternatives for antibodies in CAT detection assays. _h[electronic resource] |
260 |
_bJournal of applied toxicology : JAT _cOct 2012 |
||
300 |
_a783-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntibody Affinity |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
650 | 0 | 4 |
_aBacteriophages _xdrug effects |
650 | 0 | 4 |
_aChloramphenicol O-Acetyltransferase _xantagonists & inhibitors |
650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
650 | 0 | 4 | _aGene Library |
650 | 0 | 4 |
_aGenes, Reporter _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLimit of Detection |
650 | 0 | 4 |
_aOperator Regions, Genetic _xdrug effects |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
650 | 0 | 4 | _aProtein Array Analysis |
650 | 0 | 4 |
_aRecombinant Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aSingle-Chain Antibodies _xchemistry |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aSurface Plasmon Resonance |
650 | 0 | 4 |
_aToxicology _xmethods |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
700 | 1 | _aMehta, Jaytry | |
700 | 1 | _aRouah-Martin, Elsa | |
700 | 1 | _aBackeljau, Jelke | |
700 | 1 | _aDe Coen, Wim | |
700 | 1 | _aEeckhout, Dominique | |
700 | 1 | _aDe Jaeger, Geert | |
700 | 1 | _aBlust, Ronny | |
700 | 1 | _aRobbens, Johan | |
773 | 0 |
_tJournal of applied toxicology : JAT _gvol. 32 _gno. 10 _gp. 783-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jat.1685 _zAvailable from publisher's website |
999 |
_c20766070 _d20766070 |